Medication adherence: A call for action

详细信息    查看全文

• 作者：Hayden B. Bosworth PhD^a ;   ; ^b ;   ; ^c ;   ; ^{hayden.bosworth@duke.edu} ; Bradi B. Granger RN ; PhD^d ; Phil Mendys Pharm D^e ; Ralph Brindis MD^f ; Rebecca Burkholder JD^g ; Susan M. Czajkowski PhD^h ; Jodi G. Daniel JD ; MPHⁱ ; Inger Ekman PhD^j ; Michael Ho MD^k ; Mimi Johnson MPhil^g ; Stephen E. Kimmel MD ; MSCE^l ; Larry Z. Liu MD ; PhD^m ; John Musausⁿ ; William H. Shrank MD ; MSHS^o ; Elizabeth Whalley Buono RN ; JDⁿ ; Karen Weiss^p ; Christopher B. Granger MD^q
• 刊名：American Heart Journal
• 出版年：2011
• 出版时间：September 2011
• 年：2011
• 卷：162
• 期：3
• 页码：412-424
• 全文大小：231 K

文摘

Poor adherence to efficacious cardiovascular-related medications has led to considerable morbidity, mortality, and avoidable health care costs. This article provides results of a recent think-tank meeting in which various stakeholder groups representing key experts from consumers, community health providers, the academic community, decision-making government officials (Food and Drug Administration, National Institutes of Health, etc), and industry scientists met to evaluate the current status of medication adherence and provide recommendations for improving outcomes. Below, we review the magnitude of the problem of medication adherence, prevalence, impact, and cost. We then summarize proven effective approaches and conclude with a discussion of recommendations to address this growing and significant public health issue of medication nonadherence.